Advertisement

Topics

TARCEVA Company Profile

11:07 EDT 19th September 2018 | BioPortfolio

Nil

Location

Suite 11058 South Service Road
Melville
New York
11747
United States of America

Contact

Phone: (631) 962-2000
Fax: (631) 752-3880
Email: customer.service@gene.com


Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Tarceva(erlotinib)tablets [OSI Pharmaceuticals Inc.]

TARCEVA(erlotinib)Tablets

Tarceva [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use In...

PubMed Articles [0 Results]

None

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

This is a multicenter, open-label, randomized phase 1 study of escalating doses of Tarceva in patients with advanced NSCLC who currently smoke. Part I will establish the maximum tolerated...

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

The purpose of this study is test the safety of Tarceva, find the best dose, and see what effects (good and bad) it has on you and your colorectal cancer. The effects of Tarceva will be e...

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

This is a phase II study of Bevacizumab plus Temodar and Tarceva in patients with non-progressive glioblastoma or gliosarcoma. Patients must have stable disease immediately following a sta...

A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer

This study is designed to identify biomarkers which may predict improvement in progression free survival from treatment with Tarceva, in patients with advanced pancreatic cancer who failed...

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

This study will compare the efficacy and safety of escalating versus standard doses to rash of Tarceva, in combination with gemcitabine, in patients with metastatic pancreatic cancer. Duri...

Companies [3 Associated Companies listed on BioPortfolio]

TARCEVA

Nil

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality o...

Hana Biosciences, Inc.

Hana Biosciences, Inc. (Nasdaq: HNAB) is a biopharmaceutical company dedicated to developing new, differentiated cancer therapies designed to improve and enable current standards of care. The Com...

More Information about "TARCEVA" on BioPortfolio

We have published hundreds of TARCEVA news stories on BioPortfolio along with dozens of TARCEVA Clinical Trials and PubMed Articles about TARCEVA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARCEVA Companies in our database. You can also find out about relevant TARCEVA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record